Search

Search Funnelback University

Search powered by Funnelback
1 - 16 of 16 search results for `Search news` |u:emit.medschl.cam.ac.uk
  1. Fully-matching results

  2. Awards! Archives - Experimental Medicine and Immunotherapeutics (EMIT)

    https://emit.medschl.cam.ac.uk/blog/category/awards/
    23 Feb 2024: Libraries & facilities. Museums & collections. Email & phone search. Site Search. ... Dr Viknesh Selvarajah won the Young Investigator Prize […]. Filed Under:Site Search.
  3. Uncategorised Archives - Experimental Medicine and Immunotherapeutics …

    https://emit.medschl.cam.ac.uk/blog/category/uncategorised/
    23 Feb 2024: Libraries & facilities. Museums & collections. Email & phone search. Site Search. ... Two of the schemes are co-funded by the NIHR Cambridge Biomedical Research Centre, a partnership between Cambridge University Hospitals and […]. Filed Under:Site
  4. Prizes awarded - Experimental Medicine and Immunotherapeutics (EMIT)

    https://emit.medschl.cam.ac.uk/blog/2016/10/07/prizes-awarded/
    23 Feb 2024: Libraries & facilities. Museums & collections. Email & phone search. Site Search. ... Filed Under:Site Search. Recent Posts. Archives. Our Research is funded by.
  5. Kat Connolly awarded a Young Investigator prize - Experimental…

    https://emit.medschl.cam.ac.uk/blog/2018/10/31/kat-connolly-awarded-a-young-investigator-prize/
    23 Feb 2024: Experimental Medicine and Immunotherapeutics (EMIT). News. Kat Connolly awarded a Young Investigator prize. ... Site Search. Recent Posts. Archives. Our Research is funded by. Contact us.
  6. Innovative Vitamin D Trial Funded by NIHR HTA - Experimental Medicine …

    https://emit.medschl.cam.ac.uk/blog/2015/10/07/innovative-vitamin-d-trial-funded-by-nihr-hta/
    23 Feb 2024: Experimental Medicine and Immunotherapeutics (EMIT). News. Innovative Vitamin D Trial Funded by NIHR HTA. ... Site Search. Recent Posts. Archives. Our Research is funded by. Contact us.
  7. Losmapimod Phase III Clinical Trial Announced by GSK - Experimental…

    https://emit.medschl.cam.ac.uk/blog/2014/07/08/losmapimod-phase-iii-clinical-trial-announced-by-gsk/
    23 Feb 2024: Experimental Medicine and Immunotherapeutics (EMIT). News. Losmapimod Phase III Clinical Trial Announced by GSK. ... For more information please click on the links below:. Filed Under: News.
  8. AIM HY INFORM Clinical Trial now recruiting participants -…

    https://emit.medschl.cam.ac.uk/blog/2017/09/18/aim-hy-inform-clinical-trial-now-recruiting-participants/
    23 Feb 2024: Experimental Medicine and Immunotherapeutics (EMIT). News. AIM HY INFORM Clinical Trial now recruiting participants. ... This is an HRA Approved Study IRAS No 199550. Filed Under: News.
  9. 'Tomato pill’ improves function of blood vessels - Experimental…

    https://emit.medschl.cam.ac.uk/blog/2014/06/10/tomato-pill-improves-function-of-blood-vessels/
    23 Feb 2024: Experimental Medicine and Immunotherapeutics (EMIT). News. ‘Tomato pill’ improves function of blood vessels. ... Site Search. Recent Posts. Archives. Our Research is funded by. Contact us.
  10. Treatment for heart attack patients - a step closer - Experimental…

    https://emit.medschl.cam.ac.uk/blog/2014/07/08/treatment-for-heart-attack-patients-a-step-closer/
    23 Feb 2024: Experimental Medicine and Immunotherapeutics (EMIT). News. Treatment for heart attack patients – a step closer. ... Site Search. Recent Posts. Archives. Our Research is funded by. Contact us.
  11. Lecture by Dr Dike Ojji - African collaborator on AIM HY Study…

    https://emit.medschl.cam.ac.uk/blog/2017/11/06/lecture-dr-dike-ojji-african-collaborator-aim-hy-study-hypertension/
    23 Feb 2024: Site Search. Lecture by Dr Dike Ojji – African collaborator on AIM HY Study (Hypertension). ... Experimental Medicine and Immunotherapeutics (EMIT). News. Lecture by Dr Dike Ojji – African collaborator on AIM HY Study (Hypertension).
  12. Cambridge to lead MRC/BHF funded trial for AIMHY consortium -…

    https://emit.medschl.cam.ac.uk/blog/2015/01/29/cambridge-to-lead-mrcbhf-funded-trial-for-aimhy-consortium/
    23 Feb 2024: Site Search. Cambridge to lead MRC/BHF funded trial for AIMHY consortium. ... Experimental Medicine and Immunotherapeutics (EMIT). News. Cambridge to lead MRC/BHF funded trial for AIMHY consortium.
  13. Dr Peiran (Brian) Yang receives the British Pharmacological Society…

    https://emit.medschl.cam.ac.uk/blog/2018/02/12/dr-peiran-brian-yang-receives-british-pharmacological-society-2017-vogt-prize/
    23 Feb 2024: Site Search. Dr Peiran (Brian) Yang receives the British Pharmacological Society 2017 Vogt Prize. ... Experimental Medicine and Immunotherapeutics (EMIT). News. Dr Peiran (Brian) Yang receives the British Pharmacological Society 2017 Vogt Prize.
  14. Astrazeneca and Cambridge announce new joint PhD and clinical…

    https://emit.medschl.cam.ac.uk/blog/2015/06/30/astrazeneca-and-cambridge-announce-new-joint-phd-and-clinical-research-scholoarship/
    23 Feb 2024: Site Search. Astrazeneca and Cambridge announce new joint PhD and clinical research scholarship. ... Experimental Medicine and Immunotherapeutics (EMIT). News. Astrazeneca and Cambridge announce new joint PhD and clinical research scholarship.
  15. Dr Maki-Petaja winning a poster prize at the Artery Conference in…

    https://emit.medschl.cam.ac.uk/blog/2018/11/15/dr-maki-petaja-winning-a-poster-prize-at-the-artery-conference-in-guimaraes-portugal/
    23 Feb 2024: Site Search. Dr Maki-Petaja winning a poster prize at the Artery Conference in Guimaraes, Portugal. ... Experimental Medicine and Immunotherapeutics (EMIT). News. Dr Maki-Petaja winning a poster prize at the Artery Conference in Guimaraes, Portugal.
  16. MRC, GSK and five leading UK universities collaborate to crack…

    https://emit.medschl.cam.ac.uk/blog/2015/07/15/mrc-gsk-and-five-leading-uk-universities-collaborate-to-crack-difficult-disease-areas/
    23 Feb 2024: Site Search. MRC, GSK and five leading UK universities collaborate to crack difficult disease areas. ... Experimental Medicine and Immunotherapeutics (EMIT). News. MRC, GSK and five leading UK universities collaborate to crack difficult disease areas.
  17. Researchers use simple chemicals to minimise organ damage following…

    https://emit.medschl.cam.ac.uk/blog/2014/11/05/researchers-use-simple-chemicals-to-minimise-organ-damage-following-heart-attack-and-stroke/
    23 Feb 2024: Site Search. Researchers use simple chemicals to minimise organ damage following heart attack and stroke. ... Experimental Medicine and Immunotherapeutics (EMIT). News. Researchers use simple chemicals to minimise organ damage following heart attack and

Refine your results

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.